Details
Precision Molecular Pathology of Lung Cancer
Molecular Pathology Library 2nd ed. 2018
|
85,59 € |
|
| Verlag: | Springer |
| Format: | |
| Veröffentl.: | 10.11.2017 |
| ISBN/EAN: | 9783319629414 |
| Sprache: | englisch |
Dieses eBook enthält ein Wasserzeichen.
Beschreibungen
<div>This new edition provides the latest information and insights into the molecular basis for lung cancer. Since the publication of the previous edition of this volume, dramatic changes have occurred with the classification of lung cancer, biomarker testing, and molecular therapy. The book covers these changes, providing updates and new insights on the background of lung cancer, testing methods, and the molecular pathology of specific cell types, including adenocarcinoma, squamous cell carcinoma, small cell carcinoma, and precursor and preinvasive lesions.</div><div><br/></div><div>Authored by experts in the field, <i>Precision Molecular Pathology of Lung Cancer, Second Edition </i>remains one of the few books that comprehensively covers the new molecular pathology of lung cancer and is a valuable resource for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, and thoracic radiologists.</div>
I. Background.- 1. Precision Medicine of Lung Cancer: Introduction.- 2. Lung Cancer Epidemiology and Demographics.- 3. Genetic Susceptibility to Lung Cancer.- 4. Lung Cancer Stem Cells.- 5. The 2015 World Health Organization Classification of Lung Cancer: Overview.- II. Testing Methods.- 6. Preanalytic considerations.- 7. Mutation testing of lung cancer biomarkers.- 8. Translocation testing of lung cancer biomarkers.- 9. Immunohistochemistry of lung cancer biomarkers.- 10. Next Generation and Third Generation Sequencing of lung cancer biomarkers.- III. Molecular Pathology of Specific Cell Types.- 11. Mutations as Predictive Biomarkers for Adenocarcinoma.- 12. Translocations as predictive Biomarkers for Adenocarcinoma.- 13. Predictive Biomarkers for Squamous Cell Carcinoma.- 14. Molecular Pathology of Small Cell Carcinoma.- 15. Molecular Pathology of Uncommon Carcinomas.- 16. Molecular Pathology of Lung Cancer Metastases.- 17. Molecular Pathology of Precursor and Preinvasive Lesions.- IV. General and Emerging Fields in Molecular Pathology of Lung Cancer.- 18. Prognostic biomarkers in lung cancer.- 19. Biomarkers and Differing Therapy Modalities.- 20. Immuno-oncology of Lung Cancer.- 21. Liquid Biopsy.<br>
<p>Philip T. Cagle, MD</p><p>Houston Methodist Hospital</p><p>Department of Pathology & Genomic Medicine</p><p>6565 Fannin St</p><p>Houston, TX 77030</p><p><br/></p><p>Timothy C. Allen, MD</p><p>The University of Texas Medical Branch </p><p>Department of Pathology</p><p>301 University Boulevard</p><p>Galveston, TX 77555</p><p><br/></p><p>Mary Beth Beasley, MD</p><p></p>Mount Sinai Hospital<p></p><p>Department of Pathology</p><p>1468 Madison Avenue</p><p>New York, NY 10029</p><p><br/></p><p>Lucian R. Chirieac, MD</p><p>Brigham And Women's Hospital</p><p>Department of Pathology</p><p>75 Francis St.</p><p>Boston, MA 02115</p><p><br/></p><p>Sanja Dacic, MD, PhD</p><p>University of Pittsburgh Medical Center</p><p>Department of Pathology</p><p></p>200 Lothrop St.<p></p><p>Pittsburgh, PA 15213</p><p><br/></p><p>Alain C. Borczuk, MD</p><p>Weill Cornell University Medical Center</p><p>Department of Pathology</p><p>1300 York Avenue</p><p>Starr-1000A</p><p>New York, NY 10065</p><p><br/></p><p>Keith M. Kerr, MD</p><p>Aberdeen University Medical School</p><p>Aberdeen Royal Infirmary</p><p>Department of Pathology</p><p></p>Foresterhill<p></p><p>Aberdeen, Scotland</p><p><br/></p><p>Lynette Sholl, MD</p><p>Brigham And Women's Hospital</p><p>Department of Pathology</p><p>75 Francis St</p><p>Boston, MA 02115</p><p><br/></p><p>Bryce Portier, MD</p><p>Houston Methodist Hospital</p><p>Department of Pathology & Genomic Medicine</p><p>6565 Fannin St</p><p>Houston, TX 77030</p><p></p><br/><p></p><p>Eric Bern</p>icker, MD<p></p><p>Houston Methodist Hospital</p><p>Thoracic Medical Oncology</p><p>6445 Main St, Floor 21</p><p>Houston, TX 77030 </p>
<div>This new edition provides the latest information and insights into the molecular basis for lung cancer. Since the publication of the previous edition of this volume, dramatic changes have occurred with the classification of lung cancer, biomarker testing, and molecular therapy. The book covers these changes, providing updates and new insights on the background of lung cancer, testing methods, and the molecular pathology of specific cell types, including adenocarcinoma, squamous cell carcinoma, small cell carcinoma, and precursor and preinvasive lesions.</div><div><br/></div><div>Authored by experts in the field, <i>Precision Molecular Pathology of Lung Cancer, Second Edition </i>remains one of the few books that comprehensively covers the new molecular pathology of lung cancer and is a valuable resource for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, and thoracic radiologists.</div>
Provides the most updated knowledge on biomarker testing and molecular therapy of lung cancer Details the molecular pathology of specific cell types Written by experts in the field
<p>Provides the most updated knowledge on biomarker testing and molecular therapy of lung cancer</p><p>Details the molecular pathology of specific cell types<br/></p><p>Written by experts in the field<br/></p>
Diese Produkte könnten Sie auch interessieren:
Razum prestupnika i logika prestupleniya. O psihiatrii, sudah i seriynyh ubiytsah
von: Shohom Das, Dmitry Chepusov
6,99 €
